The Psychedelic Morning Brief
Monday, September 14, 2026 🏛️ The FDA Wants Psychedelic Treatments to Reach Patients Faster Synopsis: The FDA is supporting faster development & review of Psychedelic medicines through priority vouchers, finalized clinical-trial guidance & new research. Its efforts include Psilocybin for depression, Methylone for PTSD & an early-stage study of